首页|DNA倍体分析联合HPV DNA检测在子宫颈病变筛查中的应用价值研究

DNA倍体分析联合HPV DNA检测在子宫颈病变筛查中的应用价值研究

扫码查看
目的 探讨DNA倍体分析联合HPV DNA检测在子宫颈病变筛查中的应用价值.方法 选取2021年1~6月在上海市长宁区妇幼保健院进行子宫颈病变筛查的患者,先行DNA倍体分析检查,结果异常者再行HPV DNA检测,最后对二者均阳性的患者行子宫颈活检采样,并分别与子宫颈活检的病理结果相对比.结果 共对9126例子宫颈样本行DNA倍体检查,检查结果异常者680例,经HPV DNA联合检测后行阴道镜子宫颈活检采样送病理检查者503例,结果显示子宫颈癌、高级别鳞状上皮内病变(HSIL)、低级别鳞状上皮内病变(LSIL)、子宫颈炎的占比分别为 1.6%(8/503)、11.5%(58/503)、41.4%(208/503)和 45.5%(229/503).DNA 倍体异常细胞≥3 个组的LSIL及以上的阳性率为39.1%(107/274),联合HPV DNA检测后,LSIL及以上的阳性率提高到99.6%(275/276),两组阳性率比较差异有统计学意义(P<0.05),而阴性率比较差异无统计学意义(P>0.05).结论 DNA倍体分析联合HPV DNA检测,在阴性率保持不变的情况下能够提高子宫颈病变筛查的阳性率,具有临床意义.
Application study of DNA ploidy analysis combined with HPV DNA detection in screening of cervical lesions
Objective To explore the application value of DNA ploidy analysis combined with HPV DNA detection in screening cervical lesions.Methods Patients who underwent cervical lesion screening at Changning District Maternal and Child Health Hospital in Shanghai from January to June 2021 were selected.DNA ploidy analysis was performed first,and HPV DNA testing was performed for those with abnormal results.Finally,cervical biopsy samples were taken for patients who were both positive,and were compared with the pathological results of cervical biopsy.Results A total of 9126 cervical samples underwent DNA ploidy examination,with 680 cases showing abnormal results.After HPV DNA combined detection,503 cases underwent hysteroscopic cervical biopsy and were sent for pathological examination.The results showed that the proportions of cervical cancer,high-grade squamous intraepithelial lesions(HSIL),low-grade squamous intraepithelial lesions(LSIL),and cervicitis were 1.6%(8/503),11.5%(58/503),41.4%(208/503),and 45.5%(229/503),respectively.The positive rate of LSIL and above in groups with DNA ploidy abnormalities≥3 was 39.1%(107/274).After combined HPV DNA examination,the positive rate of LSIL and above was increased to 99.6%(275/276).The difference in positive rates between the two groups was statistically significant(P<0.05),while the dif-ference in negative rates was not statistically significant(P>0.05).Conclusion The combination of DNA ploidy analy-sis with HPV DNA detection can improve the positive rate of cervical lesion screening while maintaining the same nega-tive rate,which has clinical significance.

DNA ploidy analysishuman papillomaviruscervical lesions

杨玲、骆莺、杨安强

展开 >

上海市长宁区妇幼保健院,上海 200050

DNA倍体分析 人乳头瘤病毒 子宫颈病变

国家自然科学基金

81972709

2024

中国实用妇科与产科杂志
中国医师协会 中国实用医学杂志社

中国实用妇科与产科杂志

CSTPCD北大核心
影响因子:1.97
ISSN:1005-2216
年,卷(期):2024.40(3)
  • 23